Salvage Prostate SBRT with the CyberKnife® System
Sean P. Collins, M.D., Ph.D., Professor and Vice Chair of Faculty Affairs, Department of Radiation Oncology, Tampa General Hospital, Morsani College of Medicine, University of South Florida, FL | AEx Academy ASTRO 2024
Treatment of intermediate unfavorable, high- and very-high risk prostate cancer with SBRT: a multi-institutional analysis
This content is only accessible to select Accuray Exchange (AEx) members. Username Password Remember Me Forgot Password
Initial experience of Radixact® Synchrony® tracking on cancer in prostate and lung
This content is only accessible to select Accuray Exchange (AEx) members.
SBRT for High-Risk Prostate Cancer
This content is only accessible to select Accuray Exchange (AEx) members.
17 years of CyberKnife® System SBRT for Prostate Cancer
This content is only accessible to select Accuray Exchange (AEx) members.
What We Have Learnt from PACE Multicenter, International Phase 3 Randomized Controlled Study
This content is only accessible to select Accuray Exchange (AEx) members.
Prostate SBRT and the PACE-B Trial
Alison Tree, MBBS, BSc, FRCR, M.D.(Res) | Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, UK | ASTRO 2022 AEx Academy
Clinical Value of Motion Synchronization for Prostate SBRT
Sean Collins, M.D., Ph.D. | MedStar Georgetown University Hospital, Georgetown University School of Medicine, Washington, D.C. | ASTRO 2022 AEx Academy
Long-Term Outcomes from a Multi-Center Trial of Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
This content is only accessible to select Accuray Exchange (AEx) members.
Stereotactic Body Radiation Therapy in Treating Patients with Oligo-metastatic Hormone-Naïve Prostate Cancer
This content is only accessible to select Accuray Exchange (AEx) members.
